These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36182775)

  • 1. Inhibition of HIPK2 protects stress-induced pathological cardiac remodeling.
    Zhou Q; Meng D; Li F; Zhang X; Liu L; Zhu Y; Liu S; Xu M; Deng J; Lei Z; Sluijter JPG; Xiao J
    EBioMedicine; 2022 Nov; 85():104274. PubMed ID: 36182775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exercise downregulates HIPK2 and HIPK2 inhibition protects against myocardial infarction.
    Zhou Q; Deng J; Yao J; Song J; Meng D; Zhu Y; Xu M; Liang Y; Xu J; Sluijter JP; Xiao J
    EBioMedicine; 2021 Dec; 74():103713. PubMed ID: 34837851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting miR-30d reverses pathological cardiac hypertrophy.
    Li J; Sha Z; Zhu X; Xu W; Yuan W; Yang T; Jin B; Yan Y; Chen R; Wang S; Yao J; Xu J; Wang Z; Li G; Das S; Yang L; Xiao J
    EBioMedicine; 2022 Jul; 81():104108. PubMed ID: 35752105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrin beta-like 1 mediates fibroblast-cardiomyocyte crosstalk to promote cardiac fibrosis and hypertrophy.
    Chen X; Li X; Wu X; Ding Y; Li Y; Zhou G; Wei Y; Chen S; Lu X; Xu J; Liu S; Li J; Cai L
    Cardiovasc Res; 2023 Aug; 119(10):1928-1941. PubMed ID: 37395147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C1q-TNF-related protein-3 attenuates pressure overload-induced cardiac hypertrophy by suppressing the p38/CREB pathway and p38-induced ER stress.
    Zhang B; Zhang P; Tan Y; Feng P; Zhang Z; Liang H; Duan W; Jin Z; Wang X; Liu J; Gao E; Yu S; Yi D; Sun Y; Yi W
    Cell Death Dis; 2019 Jul; 10(7):520. PubMed ID: 31285424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diminished arachidonate 5-lipoxygenase perturbs phase separation and transcriptional response of Runx2 to reverse pathological ventricular remodeling.
    Xie S; Chen M; Fang W; Liu S; Wu Q; Liu C; Xing Y; Shi W; Xu M; Zhang M; Chen S; Zeng X; Wang S; Deng W; Tang Q
    EBioMedicine; 2022 Dec; 86():104359. PubMed ID: 36395739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The TIR/BB-loop mimetic AS-1 attenuates mechanical stress-induced cardiac fibroblast activation and paracrine secretion via modulation of large tumor suppressor kinase 1.
    Fan M; Song J; He Y; Shen X; Li J; Que L; Zhu G; Zhu Q; Cai X; Ha T; Chen Q; Xu Y; Li C; Li Y
    Biochim Biophys Acta; 2016 Jun; 1862(6):1191-202. PubMed ID: 26964796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mixed lineage kinase-3 prevents cardiac dysfunction and structural remodeling with pressure overload.
    Calamaras TD; Baumgartner RA; Aronovitz MJ; McLaughlin AL; Tam K; Richards DA; Cooper CW; Li N; Baur WE; Qiao X; Wang GR; Davis RJ; Kapur NK; Karas RH; Blanton RM
    Am J Physiol Heart Circ Physiol; 2019 Jan; 316(1):H145-H159. PubMed ID: 30362822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CITED4 Protects Against Adverse Remodeling in Response to Physiological and Pathological Stress.
    Lerchenmüller C; Rabolli CP; Yeri A; Kitchen R; Salvador AM; Liu LX; Ziegler O; Danielson K; Platt C; Shah R; Damilano F; Kundu P; Riechert E; Katus HA; Saffitz JE; Keshishian H; Carr SA; Bezzerides VJ; Das S; Rosenzweig A
    Circ Res; 2020 Aug; 127(5):631-646. PubMed ID: 32418505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mnk1 (Mitogen-Activated Protein Kinase-Interacting Kinase 1) Deficiency Aggravates Cardiac Remodeling in Mice.
    Yuan Y; Yan L; Wu QQ; Zhou H; Jin YG; Bian ZY; Deng W; Yang Z; Shen DF; Zeng XF; Wang SS; Li H; Tang QZ
    Hypertension; 2016 Dec; 68(6):1393-1399. PubMed ID: 27698061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaspin Ameliorates Cardiac Remodeling by Suppressing Phosphoinositide 3-Kinase/Protein Kinase B Pathway to Improve Oxidative Stress in Heart Failure Rats.
    Ji M; Li Y; Liu Y; Ma G
    J Cardiovasc Pharmacol; 2022 Sep; 80(3):442-452. PubMed ID: 36067399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac fibroblast miR-27a may function as an endogenous anti-fibrotic by negatively regulating Early Growth Response Protein 3 (EGR3).
    Teng L; Huang Y; Guo J; Li B; Lin J; Ma L; Wang Y; Ye C; Chen Q
    J Cell Mol Med; 2021 Jan; 25(1):73-83. PubMed ID: 33215816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiomyocyte Homeodomain-Interacting Protein Kinase 2 Maintains Basal Cardiac Function via Extracellular Signal-Regulated Kinase Signaling.
    Guo Y; Sui JY; Kim K; Zhang Z; Qu XA; Nam YJ; Willette RN; Barnett JV; Knollmann BC; Force T; Lal H
    Circulation; 2019 Nov; 140(22):1820-1833. PubMed ID: 31581792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effects of METRNL overexpression against pathological cardiac remodeling.
    Cao H; Liao Y; Hong J
    Gene; 2024 Apr; 901():148171. PubMed ID: 38242372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zerumbone prevents pressure overload-induced left ventricular systolic dysfunction by inhibiting cardiac hypertrophy and fibrosis.
    Sari N; Katanasaka Y; Sugiyama Y; Sunagawa Y; Miyazaki Y; Funamoto M; Shimizu S; Shimizu K; Murakami A; Mori K; Wada H; Hasegawa K; Morimoto T
    Phytomedicine; 2021 Nov; 92():153744. PubMed ID: 34563985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ubiquitin-specific protease 19 blunts pathological cardiac hypertrophy via inhibition of the TAK1-dependent pathway.
    Miao R; Lu Y; He X; Liu X; Chen Z; Wang J
    J Cell Mol Med; 2020 Sep; 24(18):10946-10957. PubMed ID: 32798288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochanin A inhibits cardiac hypertrophy and fibrosis in vivo and in vitro.
    Feng Z; Zhang N; Bai J; Lin QY; Xie Y; Xia YL
    Biomed Pharmacother; 2024 Jan; 170():116002. PubMed ID: 38091641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delphinidin attenuates pathological cardiac hypertrophy via the AMPK/NOX/MAPK signaling pathway.
    Chen Y; Ge Z; Huang S; Zhou L; Zhai C; Chen Y; Hu Q; Cao W; Weng Y; Li Y
    Aging (Albany NY); 2020 Mar; 12(6):5362-5383. PubMed ID: 32209725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knockdown of HIPK2 Attenuates Angiotensin II-Induced Cardiac Fibrosis in Cardiac Fibroblasts.
    Xu F; Mao B; Li Y; Zhao Y
    J Cardiovasc Pharmacol; 2022 Jul; 80(1):125-131. PubMed ID: 35522151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel Inhibitor of Homeodomain Interacting Protein Kinase 2 Mitigates Kidney Fibrosis through Inhibition of the TGF-
    Liu R; Das B; Xiao W; Li Z; Li H; Lee K; He JC
    J Am Soc Nephrol; 2017 Jul; 28(7):2133-2143. PubMed ID: 28220029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.